The efficacy of an antibiotic in human or experimental infection is pr
esumed to be proportional to its in vitro antimicrobial activity, yet
antibiotics having comparable in vitro activity may have markedly diff
erent efficacies in vivo. For example, we have reported that clindamyc
in is more efficacious than penicillin in experimental gas gangrene ca
used by Clostridium perfringens in animals. To explain these differenc
es, we compared the dynamics of bacterial killing and suppression of t
oxin synthesis. In addition, we investigated the ability of clindamyci
n and penicillin to modulate lipopolysaccharide-induced cytokine produ
ction in human peripheral blood mononuclear cells. Our results suggest
that clindamycin affects protein synthesis in both prokaryotic and eu
karyotic cells. These data may, in part, explain why the efficacy of c
lindamycin is greater than that of penicillin and demonstrate that cli
ndamycin may be an important immune modulator.